Compare dividend stocks

ABBV vs MRK

AbbVie Inc. provides a 2.72% dividend yield, marginally above Merck & Company, Inc.'s 2.67%. Merck boasts a 14-year dividend streak and slightly better 3-year and 5-year CAGRs, though AbbVie leads in trailing twelve-month growth. In terms of safety and valuation, Merck is rated "watch" and "fair" by yield theory, unlike AbbVie which is "at_risk" and "overvalued."

ABBV AB
ABBV
MRK MR
MRK

Key differences

Yield

ABBV AB
ABBV

2.60%

MRK 2.23%

CAGR 5y

MRK MR
MRK

+6.8%

ABBV +6.8%

Safety

ABBV At risk

MRK At risk

Dividend score

ABBV 3/10

MRK 3/10

ABBV AB
ABBV Yield Growth Momentum Safety Value Health
3 · Weak At risk
MRK MR
MRK Yield Growth Momentum Safety Value Health
3 · Weak At risk

Price

266.0 USD 152.2 USD

Today

+2.7% +12.6%

Dividend/share

6.9 USD 3.4 USD

2.60% 2.23%

Growth (TTM)

+5.6% +5.0%

CAGR 3y

+5.2% +5.5%

+6.8% +6.8%

12y 14y

Dividend status

Contender (10y+) Contender (10y+)

10.6y 10.5y

Dividend score

3/10 3/10

Safety

At risk At risk

Quantic · Free

Unlock the full valuation comparison

Chowder number, fair value and Dividend Yield Theory for every stock — plus track them in your portfolio.

€0

Need more? Pro adds portfolios, options income tracking & more AI. See Pro →